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Abstract
Background: Until recently, genome-wide association studies (GWAS) have been restricted to research groups with
the budget necessary to genotype hundreds, if not thousands, of samples. Replacing individual genotyping with
genotyping of DNA pools in Phase I of a GWAS has proven successful, and dramatically altered the financial
feasibility of this approach. When conducting a pool-based GWAS, how well SNP allele frequency is estimated from
a DNA pool will influence a study’s power to detect associations. Here we address how to control the variance in
allele frequency estimation when DNAs are pooled, and how to plan and conduct the most efficient well-powered
pool-based GWAS.
Methods: By examining the variation in allele frequency estimation on SNP arrays between and within DNA pools
we determine how array variance [var(earray)] and pool-construction variance [var(econstruction)] contribute to the
total variance of allele frequency estimation. This information is useful in deciding whether replicate arrays or
replicate pools are most useful in reducing variance. Our analysis is based on 27 DNA pools ranging in size from
74 to 446 individual samples, genotyped on a collective total of 128 Illumina beadarrays: 24 1M-Single, 32 1M-Duo,
and 72 660-Quad.
Results: For all three Illumina SNP array types our estimates of var(earray) were similar, between 3-4 × 10
-4 for
normalized data. Var(econstruction) accounted for between 20-40% of pooling variance across 27 pools in normalized
data.
Conclusions: We conclude that relative to var(earray), var(econstruction) is of less importance in reducing the variance
in allele frequency estimation from DNA pools; however, our data suggests that on average it may be more
important than previously thought. We have prepared a simple online tool, PoolingPlanner (available at http://
www.kchew.ca/PoolingPlanner/), which calculates the effective sample size (ESS) of a DNA pool given a range of
replicate array values. ESS can be used in a power calculator to perform pool-adjusted calculations. This allows one
to quickly calculate the loss of power associated with a pooling experiment to make an informed decision on
whether a pool-based GWAS is worth pursuing.
Background
Genome-wide association studies (GWAS) have been
used to examine over 200 diseases and traits, and identi-
fied over 4000 single nucleotide polymorphisms (SNPs)
associated with these traits, as listed in the Catalog of
Published Genome-Wide Association Studies [1]. In
many cases, GWAS have revealed previously
unsuspected molecular mechanisms of disease, high-
lighting the value of this hypothesis-free approach
[reviewed in [2,3]]. Unfortunately, GWAS are very costly
due to the price of genotyping thousands of individual
DNA samples on high-density SNP arrays. Conse-
quently, GWAS have only been feasible for research
groups with the necessary budget, studying well-funded
diseases or traits. A simple strategy to drastically reduce
cost is to replace individual genotyping in Phase I of a
GWAS with genotyping of DNA pools. DNA pools yield
estimated allele frequencies rather than observed
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any medium, provided the original work is properly cited.genotypes; hence, this step has been called allelotyping
[4]. Several studies have provided proof of principle for
the pooling strategy, using it to re-discover known dis-
ease-variant associations of moderate to large effect size
for a fraction of the cost of conventional GWAS [5,4].
To date, more than twenty pooled-based GWAS have
been published, many reporting genome-wide significant
associations for diseases and traits such as follicular
lymphoma, otosclerosis, multiple sclerosis, Alzheimer’s
disease, melanoma, psoriasis, and skin colour [6-12].
Depending on the number of samples being pooled, the
cost reduction in Phase I can easily reach 100 fold. Con-
sider, if a SNP array costs $250 and there are 2000 cases
and 2000 controls to genotype, a million dollars is
required for Phase I individual genotyping alone. Con-
versely, the pool-based experiment using 12 replicate
arrays on two pools (case and control) would be $6000,
or 0.6% of the cost. Simply put, a pooling GWAS is fea-
sible for most grant budgets, while an individual geno-
typing GWAS is not. The criticism of pool-based
GWAS is that they have reduced power relative to con-
ventional GWAS because of errors introduced by esti-
mating allele frequency from DNA pools rather than
individual genotyping data. While it is true that pool-
based GWAS forfeit some power, these losses can be
estimated, are often less than expected, and may not
change the associations discovered. Although array costs
will continue to drop and conventional GWAS will
become more feasible, the potential savings associated
with the pooling approach will scale in proportion, leav-
ing more funds for subsequent replication, fine-map-
ping, and sequencing of associated genomic regions. For
diseases or traits with unknown biology or genetic invol-
vement, a pooling GWAS represents an economical way
to test for associations with moderate odds ratios. In
addition, work using DNA extracted from pooled whole
blood suggests that a large time-savings (50-100 fold)
may also be possible, presenting the possibility of an
incredibly fast (<1 month) and economical experiment
[5]. For a comprehensive introduction and review of
DNA pooling readers are directed to Sham et al. 2002
and Pearson et al. 2007 [13,4], and for a set of best
practices for any GWAS to Pearson & Manolio, 2008
[14].
We know that in the process of estimating allele fre-
quencies from DNA pools we introduce error, and these
must be taken into consideration to plan an adequately
powered experiment or to appropriately calculate asso-
ciation statistics [15,16]. With respect to doing this, the
most important consideration is the pooling variance
[17]; the variance in the errors arising from estimating
allele frequency from a DNA pool. Pooling variance is
the sum of many sources of variation, including in parti-
cular, array variance and pool construction variance.
A r r a yv a r i a n c ec a nb ea t t r i b u t e dt ot h o s ee r r o r sa r i s i n g
from estimating allele frequency from a DNA pool on
an SNP array [17,18]. Pool construction variance can be
attributed to those errors arising from the physical crea-
tion of a DNA pool. As pooling variance increases, the
ability of a pool-based GWAS to detect odds ratios simi-
lar to those detectable by conventional GWAS
decreases. In this report we assume pooling variance is
the sum of array variance and pool-construction var-
iance and attempt to determine which makes the greater
contribution to the pooling variance. This is relevant to
determining how best to design a pool-based GWAS
and how to allocate resources, for example, replicate
arrays can be used to reduce array variance and/or
pools can be constructed in replicate to control pool
construction variance.
Here we partition and estimate variance components
using the approach described by MacGregor [17], which
examines variation in allele frequency measurements
between and within DNA pools. Briefly, within-pool var-
iation is that observed between two arrays used to alle-
lotype the same DNA pool (i.e. replicate arrays), and is
an estimate of array variance. Between-pool variation is
that observed between two arrays used to allelotype two
different DNA pools, and is an estimate of pooling var-
iance. Estimates of array variance and pooling variance
are used to calculate pool construction variance by sub-
traction [17]. Using this approach in an analysis of two
DNA pools allelotyped on twelve Affymetrix Genechip
HindIII arrays (6 arrays per pool) MacGregor [7] found
that approximately 87.5% of pooling variation could be
attributed to the arrays, leaving 12.5% to pool-construc-
tion [17]. It was noted, however, that more data sets
would be necessary to determine the variability in these
estimates. Here we inspect 27 DNA pools allelotyped on
a total of 128 Illumina arrays, including the Human1M
Single (1M-Single), Human1M Duo (1M-Duo), and
HumanHap660 Quad (660-Quad) arrays, allowing us to
better address the question of what values array variance
and pool-construction variance are likely to take. In
addition, we perform our analysis on normalized array
data and raw array data to examine how normalization
affects pooling variance estimates.
I nt h ef i r s tp a r to ft h i ss t u d yw ee s t a b l i s hv a l u e sf o r
array variance and pool-construction variance. In the
second part, we use these estimates to calculate the
effective sample size (ESS) of a DNA pool (where ESS is
the equivalent number of samples that would need to be
individually genotyped to give a similar result) [19]. We
also present a simple online tool, PoolingPlanner, which
uses our empirical variance estimates as default values
to calculate the effective sample size (ESS) of a DNA
pool given a range of replicate array values (available at
http://www.kchew.ca/PoolingPlanner/). PoolingPlanner
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ESS can then be used in one of the available power cal-
culators, such as CaTS [20], or Quanto [21], to perform
pool-adjusted power calculations [4]. PoolingPlanner is
intended to help researchers quickly calculate the loss of
power associated with a particular pooling experiment,
which is a first step in making on informed decision on
whether a pool-based GWAS is worth pursuing.
Methods
Data
Our analysis is based on 27 DNA pools ranging in size
from 74 to 446 individual samples. These were allelo-
typed on a collective total of 128 Illumina beadarrays:
24 1M-Single, 32 1M-Duo, and 72 660-Quad. Our data-
set comprises four batches of genotyping (details given
in Additional File 1, Table S1), which correspond to
four ongoing pool-based GWAS that have not yet been
published. Each of these studies was approved by the
joint Clinical Research Ethics Board of the British
Columbia Cancer Agency and the University of British
Columbia. All subjects gave written informed consent.
Genomic DNA was extracted from peripheral venous
blood collected between 2001 and 2008 by different
laboratories using different methods. DNA samples were
diluted to 50-100 ng/uL and then quantified in duplicate
by fluorometry using PicoGreen™(Molecular Probes,
Eugene, OR, US). Pools were constructed by combining
200 ng of each sample DNA by manual pipetting. Pools
were assayed (allelotyped) at the Centre for Applied
Genomics at Sick Children’s Hospital in Toronto.”
SNP allele frequency in DNA pools was estimated
using Illumina’s beadarrays, where on average each SNP
is estimated by 16-18 “bead” observations per array (oli-
gonucleotide probes are designed to assay a SNP and
attached to beads, where individual beads are coated
with one probe type and interrogate one site in the gen-
ome) [22]. Equation 1 was used in the calculation of
each SNP allele frequency:
ˆ pi=1...n =
1
n
n 
i=1
Gi
Gi + Ri
(1)
where Gi and Ri are the green and red fluorescence
intensity for the ith bead assaying a given SNP. The two
colours correspond to the two alleles of the SNP, and n
is the number of beads assaying a given SNP, typically
16-18. Illumina beadarrays are manufactured such that
there are multiple strips on each array [22], and our
preliminary analysis revealed that unique groups of
S N P sa r ec o n s i s t e n t l yo no n l yas u b s e to fs t r i p s .F r o m
our previous experience, and that of others [18], it was
known that the average relative intensity of the red and
green channels could differ dramatically between strips
and between arrays. To prevent these manufacturing
and/or assaying properties from biasing allele frequency
estimation, a simple normalization was performed. Each
array was normalized on a strip-by-strip basis by adjust-
ing the red channel intensity to give a mean strip-wide
allele frequency estimate of 0.5 [18]. To examine the
effect of this normalization on the variance terms esti-
mated, the analyses presented in this paper are per-
formed on both normalized and raw Illumina array
data.
Statistical Analysis
Our purpose is to calculate empirical estimates of pool-
ing variance and array variance, and then to estimate
pool construction variance by subtraction. Pooling var-
iance and array variance are both estimated by calculat-
ing allele frequency differences across two paired (by
SNP, for all SNPs on the array) arrays [17]. The two
arrays used in the comparison will dictate whether an
estimate of array or pooling variance is generated. For
example, to calculate array variance, let allele frequency
estimates on arrays x used to allelotype DNA pool a be:
˜ pax = ˆ pa + earray x
where is the true allele frequency for those samples in
DNA pool a,a n de array_x is the error associated with
estimating the allele frequency from a DNA pool [15].
Then, the variance of the allele frequency difference on
two replicate arrays (x = 1, 2) is [17]:
var (˜ pa1 − ˜ pa2)=v a r( ˆ pa + earray 1 − ˆ pa − earray 2)
=v a r( earray 1 − earray 2)
=2 v a r( earray)
This yields an estimate of array variance:
var (earray)=v a r( ˜ pa1 − ˜ pa2)/2
where var (˜ pa1 − ˜ pa2) is calculated as the average of
the squared allele frequency differences for all SNPs, i (i
= 1...n), on arrays 1 and 2:
var (˜ pa1 − ˜ pa2)=
1
n − 2
n 
i=1
(˜ pa1,i − ˜ pa2,i)
2
Var(earray)i sa s s u m e dc o n s t a n tf o ra l lS N P s .I fm o r e
than two replicate arrays are used to allelotype a given
DNA pool, multiple array comparisons are possible, and
the best estimate of var(earray) is the average of all possi-
ble pairings [17].
If arrays 1 and 2 interrogate two different DNA pools,
an estimate of pooling variance can be obtained. When
two DNA pools (a, b) are constructed from identical
samples (i.e replicate pool construction),
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where var(econstruction) is the variance in the pool con-
struction errors, which are assumed to be constant for
all SNPs. Thus, an estimate of pooling variance, var
(epooling-1) is [17]:
var (epooling−1)=v a r( ˜ pa1 − ˜ pb2)/2
where “pooling-1” is used to indicate that this estimate
of pooling variance is based on the comparison of arrays
that allelotype two replicate DNA pools. As before, if
more than two replicate arrays are used to allelotype a
given DNA pool, multiple array comparisons are possi-
ble, and the best estimate of var(epooling-1) is the average
of all possible pairings [17].
When DNA pools a and b are constructed from non-
identical samples (ex. a case and control pool), an alter-
native estimate of pooling variance is var(epooling-2)
[15,17]:
var (epooling−2)=

var (˜ pa1 − ˜ pb2) − ˜ Va1,b2

/2
Here var (˜ pa1 − ˜ pb2) is calculated as the average of
the squared allele frequency difference minus a random
binomial sampling variance term, ˜ Va1,b2,f o ra l lS N P s ,i
(i = 1...n), on arrays 1 and 2:
var (epooling−2)=
1
n − 2
n 
i=1
[(˜ pa1,i − ˜ pb2,i)
2 − ˜ Va1,b2,i]/2
˜ Va1,b2 is calculated using the usual equation for bino-
mial sampling variance:
˜ Va1,b1,i = pa1,i(1 − pa1,i)/Na1 − pb2,i(1 − pb2,i)/Nb2
The random binomial sampling variance terms
accounts for the additional component of variation aris-
ing from the comparison of non-identical pools. It is
assumed that the two DNA pools are constructed from
samples drawn from the same population, and although
in fact it is often a case and control being compared
(where we specifically look for differences in allele fre-
quency), for most SNPs on an array this is a valid
assumption [15].
Figure 1 visually summarizes the three types of pair-
wise arrays comparisons used in this report, including
the sources of error in each comparison. When com-
paring arrays used to allelotype the same DNA pool
(henceforth referred to as ‘Type A’ comparisons), the
variation observed can only arise due to the arrays,
giving an estimate of array variance. When comparing
arrays used to allelotype replicate DNA pools (hence-
forth referred to as ‘Type B’ comparisons), the
variation observed is due to the arrays and pool-con-
struction, giving a direct estimate of pooling variance.
Pool-construction variance is then calculated by sub-
tracting the array variance (Type A) from the pooling
variance (Type B). If replicate DNA pools have not
been constructed, as is the case for many of the pools
i no u rd a t as e t ,w ea r es t i l la b l et oe s t i m a t et h ep o o l i n g
variance by comparing non-identical pools (henceforth
referred to as ‘Type C’ comparison) and account for
the additional binomial sampling variance term that
arises in this case. Pool-construction variance is then
calculated by subtracting Type A values from Type C
values.
Figure 1 Overview of the pair-wise array comparison’s
performed in this study. Step 1 depicts the construction of three
DNA pools. The first two pools (orange and red) are constructed
using the same DNA samples and are pool-construction replicates.
The third pool (green) is constructed using difference DNA samples.
Step 2 indicates allelotyping on Illumina SNP arrays, where the two
arrays allelotyping the orange pool are array replicate. Step 3 shows
the three types of pair-wise SNP array comparisons that can be
made, along with the sources of error that account for differences
in allele frequency estimates on the paired arrays. For Type A
comparisons, the arrays being compared were used to allelotype
the exact same DNA pool; hence, the only source of variation is the
array. For Type B comparisons, the arrays paired were used to
allelotype independently constructed but identical pools; thus,
variation may arise due to the array and the pool-construction
process. For Type C comparisons, the arrays paired were used to
allelotype completely independent DNA pools, and variation may
be due to the array, pool-construction, or binomial sampling
(assuming both pools are independent samples from a single
population).
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We assume that the array variance is comparable across
t h eD N Ap o o l si na ne x p e r i m ent, and that the average
array variance is the best estimate. For arrays with larger
than average array variance, perhaps caused greater var-
iation in PCR amplification steps and/or measurement
of allele frequency (detection of red and green fluores-
cence), array variance will be underestimated; arrays
with smaller than average array variance will be overesti-
mated. It is known that SNPs with smaller minor allele
frequencies are estimates with a greater margin of error,
i.e. var(earray) is not constant for all SNPs. For SNP with
a small minor allele frequency, average array variance
will underestimate the array variance. We also assume
that the pooling variance is constant across all SNPs,
and that unequal amplification and/or hybridization of
alleles (A or B) will have a negligible effect on results.
Because our analysis is based upon contrasting array
data from two DNA pools, the effects of unequal hybri-
dization should largely cancel out [15,18].
PoolingPlanner Theory
In choosing to conduct a pool-based GWAS, one
accepts a loss in power relative to a conventional
GWAS. How much power is lost can be expressed in
t e r m so ft h ee f f e c t i v es a m p l es i z e( N*)r e s u l t i n gf r o m
pooling N individuals [4]. PoolingPlanner uses an esti-
mate of var(epooling) to calculate the effective sample size
of a DNA pool. N* and var(epooling)a r er e l a t e dt h r o u g h
t w oe x p r e s s i o n sf o rr e l a t i v es a m p l es i z e( R S S )[ d e f i n e d
in 19]:
RSS =
N∗
N
(2)
RSS =
Vs
(Vs +v a r( epooling))
(3)
In one, the RSS of a DNA pool is expressed as the
ratio of effective sample size to the actual sample size
(N). In two, it is expressed as the fraction of the total
variance, (Vs +v a r ( e pooling)), explained by the binomial
sampling variance, Vs.V s is calculated as p(1-p)/2N,
where p is the average minor allele frequency on the
array, and N is number of individuals contributing to
the DNA pool. If DNA pools have been constructed in
replicate we let var(epooling)= var(epooling-1), otherwise we
let var(epooling)= var(epooling-2). The two equations for
RSS can then be equated and solved for N*. It is worth
noting that because our calculation of RSS relies on our
empirical estimates of var(epooling)( E q u a t i o n2 ) ,e s t i -
mates which are based on contrasting allele frequencies
in two DNA pools, the effects of unequal hybridization,
which would typically thwart a direct comparison of a
pooling-based and conventional genotyping experiment,
cancels out (15, 18).
Replicate arrays can be used to reduce var(epooling)b y
a factor of 1/k, where k is the number of replicate arrays
[4]. In making var(epooling) smaller the RSS and N*
become larger. Effective sample size can then be used
with one of the available power calculators, for example
CaTS [20] or Quanto [21] to perform pool-adjusted
power calculations [4]. PoolingPlanner is intended to
help first time users plan a DNA pooling experiment,
and our empirical estimates of array variance and pool
construction variance are supplied as the default setting
for the program for this reason. Users with their own
estimates of variances can provide these to the program
as well. PoolingPlanner is available at http://www.kchew.
ca/PoolingPlanner/).
Results
In our analyses we encountered beads with negative
intensity values in the red, green, or both channels. The
number of negative beads varied by strip and typically
affected 1-10% beads, a pattern consistently seen across
all arrays. This can occur due to local background inten-
sity removal at the point of image processing [23].
These beads were removed from our variance calcula-
tions. Furthermore, beads with zero in both the red and
green channels were considered failed beads and also
dropped from our analysis. There were typically fewer
than 100 of these per strip. Finally, SNPs having fewer
than four bead observations were excluded. The ratio-
nale for this was that SNPs having fewer than four
beads observation would have poorly estimated allele
frequency.
Array Variance or var(earray): Type A comparisons
We estimate array variance by comparing replicate
arrays, Type A comparison in Figure 1, for three types
of Illumina beadarrays, the 1M-Single, the 1M-Duo, and
the 660-Quad. The results for normalized and raw data
are given in Table 1, and box plots in Figure 2 provide a
visual summary of the estimates. Clearly normalization
dramatically reduces the range of observed array var-
iance estimates for all array types. As well, normaliza-
tion reduced the mean array variance estimate
approximately 2.5-fold for the 1M-Duo arrays and
approximately 8-fold for the 1M-Single and 660-Quad
arrays. For normalized data most estimates of array var-
iance, regardless of array type, fell between 2.5 × 10
-4
and 5.0 × 10
-4.
For the 1M-Single arrays 12 DNA pools were allelo-
typed using 24 arrays (2 arrays per pool), yielding 12
estimates of array variance, the mean of which was 3.8
×1 0
-4 (normalized) and 2.9 × 10
-3 (raw data), see Table
1. For the 1M-Duo array 8 DNA pools were analyzed
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var(earray). Three of these estimates, each from pair-wise
array comparisons involving the same array, were
extreme outliers in both the normalized and raw dataset
(see Figure 3). This array was determined faulty (see dis-
cussion) and removed from further analysis. For the
remaining 45 estimates the mean var(earray)w a s3 . 2×
10
-4 (normalized) and 9.0 × 10
-4 (raw data), see Table 1.
U n l i k et h ed a t af o rt h e1 M - S i n g l ea r r a y s ,t h e1 M - D u o
array data spanned two batches of genotyping, carried
out at two different times. To look for batch effects the
1M-Duo data was also analyzed stratified by batch. The
mean array variance was significantly different between
batches for normalized data but not raw data (based on
non-overlapping confidence intervals constructed
assuming a normal distribution). Batch 1 (18 var(earray))
and batch 2 (27 var(earray)) had mean estimates of array
variance of 4.2 × 10
-4 and 2.6 × 10
-4, respectively. For
the 660-Quad arrays, 7 pools were assayed using 72
arrays (6 or 12 arrays per pool), and mean array var-
iance was 3.3 × 10
-4 for normalized data, and 2.7 × 10
-3
for raw data, see Table 1.
Pooling Variance or var(epooling): Type B and C
comparisons
We estimate pool-construction variance for 27 DNA
pools, discussed in order by Illumina array type. Six
pools were allelotyped on the 1M-Single array, and for
each, pools were constructed in replicate and allelotyped
by two arrays. This allowed us to calculate and compare
pooling variance and pool-construction variance
Table 1 Estimates of array variance, var(earray), for three Illumina arrays types for normalized and raw data.
1M-Single 1M-Duo 660-Quad
Normalized data Var(earray) (Range) 3.8 × 10
-4
(2.2 × 10
-4 - 6.6 × 10
-4)
3.2 × 10
-4
(1.6 × 10
-4 - 6.3 × 10
-4)
3.3 × 10
-4
(2.5 × 10
-4 - 4.9 × 10
-4)
Raw data Var(earray) (Range) 2.9 × 10
-3
(3.0 × 10
-4 - 9.2 × 10
-3)
9.0 × 10
-4
(1.7 × 10
-4 - 4.3 × 10
-3)
2.7 × 10
-3
(2.0 × 10
-3 - 3.0 × 10
-3)
Number of pools 12 8 7
Number of comparisons, var(earray)
(1) 12 45
(2) 360
Number of arrays
(arrays/pool)
24 (2/pool) 32 (4/pool) 72 (6 or 12/pool)
1Each paired array comparison is treated as an independent estimate of array variance, the average of which is reported in this table.
2One array, in all 3 comparisons in which it was involved, produced extreme outlier var(earray) values and was removed from all analysis; hence, there are 45
instead of 48 var(earray) for the 1M-Duo arrays.
Figure 2 Box plots of array variance for three Illumina array
types. Box plots of var(earray(x,y)) for Illumina 1M-Duo, 1M-Single, and
660-Quad arrays for normalized and raw data. The 1M-Duo arrays
were genotyped in two batches and are plotted stratified by batch
("1M-Duo-Batch 1”, “1M-Duo-Batch 2”), as well as by array type “1M-
Duo”. The number of var(earray) estimates for each array type is: 1M-
Duo, n = 45; 1M-Duo-Batch 1, n = 18; 1M-Duo-Batch 2, n = 27; 1M-
Single, n = 11; 660-Quad, n = 360. Box plot whiskers are plotted at
the lowest datum within 1.5 the interquartile range of the lower
quartile, and the highest datum within 1.5 the interquartile range of
the upper quartile.
Figure 3 Box plots of array variance for Illumina 1M-Duo
arrays highlighting extreme outliers. Box plots of var(earray)
estimates (n = 48) for the 1M-Duo arrays (Batch 1 and 2 combined)
highlighting the three extreme outlier estimates in both normalized
and raw data, all attributable to one array. This array was
determined faulty (see discussion) and removed from all analyses.
Box plot whiskers are plotted at the lowest datum within 1.5 the
interquartile range of the lower quartile, and the highest datum
within 1.5 the interquartile range of the upper quartile.
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parison values. Figure 4 summarizes the var(epooling) and
var(econstruction) estimates for those pools on the 1M-Sin-
gle array. For normalized data var(epooling-1) ranged from
3.2 × 10
-4 to 5.5 × 10
-4 and averaged 4.0 × 10
-4. In com-
parison var(epooling-2) ranged from 3.5 × 10
-4 to 7.0 × 10
-
4 and averaged 4.8 × 10
-4. Var(econstruction-1) ranged from
0t o6 . 7×1 0
-5 and had a mean of 2.9 × 10
-5 (where
negative values have been set to zero). Thus, for these
pools var(econstruction-1) accounts for between 0 and 20%,
or an average 7.5% of the pooling variance when using
Type B derived values (see Additional File 2, Table S2
for all values). Var(econstruction-2)r a n g e df r o m0t o3 . 2×
10
-4 a n da v e r a g e d1 . 0×1 0
-4; thus, pool-construction
variance accounted for between zero and 46%, or an
average 20% of the pooling variance using Type C
derived values (Additional File 2, Table S2). There does
not appear to be any correlation between pool size and
pool-construction variance, see Figure 4.
Using raw data, estimates of var(epooling-1)w e r e
approximately 8-fold higher than the normalized data.
Estimates of var(econstruction-1)t e n d e dt ob eh i g h e ra s
well, averaging ~20% of the pooling variance. Var(epool-
ing-2) estimates followed the same pattern, larger esti-
mates of pooling variance and pool-construction
variance (data not shown).
Pools allelotyped on the 1M-Duo and 660-Quad arrays
were not constructed twice; hence, for these we esti-
mated pool-construction variance based on Type C
comparisons only. Seven DNA pools were allelotyped on
the 660-Quad array, two using six replicate arrays (396
estimates of var(epooling-2) each), and five using twelve
replicate arrays (720 estimates of var(epooling-2) per pool.
Figure 5 summarizes the var(epooling-2)a n dv a r ( e construc-
tion-2) estimates for these pools (normalized data). Var
(epooling-2) estimates ranged from 4.3 × 10
-4 to 5.7 × 10
-
4, and averaged 5.1 × 10
-4; meanwhile, the var
(econstruction-2) estimates ranged from 1.0 × 10
-4 (23%) to
2.4 × 10
-4 (42%) and averaged 1.9 × 10
-4 (35%). These
estimates of pooling variance are very similar to those
seen for pools on the 1M-Single array; however, the esti-
mates of pool-construction variance are higher (see
Additional File 3, Table S3 f o ra l lv a l u e s ) .F o rt h er a w
data var(epooling-2) estimates ranged from 2.6 × 10
-3 to
2.9 × 10
-3, and averaged 2.7 × 10
-3;m e a n w h i l e ,t h e
matched var(econstruction-2) estimates ranged from 0 to
2.6 × 10
-4 (9%) and averaged 1.9 × 10
-4 (2%).
1M-Duo arrays were analyzed separately by batch using
batch-specific estimate of array variance for normalized
data. The 1M-Duo batch 1 data contained three DNA
pools, each allelotyped by four replicate arrays; therefore,
each var(epooling-2) estimate is the average of 32 pair-wise
array comparisons. Figure 6 summarizes var(epooling-2)
and var(econstruction-2) estimates for these pools (normal-
ized data). Var(epooling-2) was estimated at 5.6 × 10
-4,6 . 0
×1 0
-4 and 6.1 × 10
-4. The matched var(econstruction-2) esti-
mates were 1.5 × 10
-4,1 . 8×1 0
-4, and 1.9 × 10
-4 , or 26%,
31%, and 32% of the pooling variance for pools sized 122,
246, and 121 (see Additional File 3, Table S3 for values).
These values reflect those seen for pools on 660-Quad
and 1M-Single arrays. In comparison, the 1M-Duo batch
2 data deviated dramatically. This batch contained 5
pools, each also alleloyped by four replicate arrays. For
these var(epooling-2)r a n g e df r o m1 . 8×1 0
-3 to 3.7 × 10
-3,
a n da v e r a g e d2 . 6×1 0
-3,a n dv a r ( e construction-2) estimates
ranging from 7.9 × 10
-4 (43%) to 2.7 × 10
-3 (72%) (see
Additional File 3, Table S3). For these pools the esti-
mates of pooling variance are nearly 2-3 fold higher than
those of batch 1 but the array variance remained low at
2.4 × 10
-4, leading to high estimates of pool-construction
variance (see discussion). For raw data batch 1 & 2 were
analyzed combined using all possible array comparisons
and var(earray)=9 . 0×1 0
-4.E s t i m a t e so fv a r ( e pooling-2)
ranged from 2.2 × 10
-3 to 5.4 × 10
-3 a n da v e r a g e d3 . 4×
Figure 4 Decomposition of pooling variance for Illumina 1M-Single arrays. Stacked barplots showing the normalized pooling variance
estimates, and the breakdown into array and to pool-construction variance for pools allelotyped on the Illumina 1M-Single array. Estimates
derived from comparison of replicate pools are labeled “B”. Estimates derived from comparison of non-identical pools are labeled “C1“ and “C2“
(specifying replicate pool). The portion of pooling variance attributed to pool-construction is indicated by hatched bars, and array variance by
black or grey bars. Pool size is shown above the barplots.
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-3.V a r ( e construction-2) estimates averaged at 51% of the
calculated var(epooling-2).
PoolingPlanner Example
To demonstrate how to use PoolingPlanner we consider
a hypothetical scenario. A researcher has a collection of
samples including 300 cases and 1000 controls and
wants to conduct a pool-based GWAS. The researcher
needs to decide how many arrays to use, and wants to
construct power curves that take into consideration the
power loss concomitant with this cost-efficient strategy.
They plan on using Illumina’s 660-Quad array and nor-
malizing their data. PoolingPlanner is used to calculate
the effective sample size of each DNA pool using four
input values: 1) var(earray), 2) var(econstruction), 3) pool
size, and 4) allele frequency. Figure 7A shows the Poo-
lingPlanner input panel for the case pool; Figure 7B the
input panel for the control pool. PoolingPlanner will
supply the var(earray) value as calculated based on our
660-Quad normalized data, 3.3 × 10
-4,s e eT a b l e2 .
Alternatively, the user may specify a custom value. In
t h i se x a m p l ew ea s s u m ev a r ( e construction) is 30% of the
pooling variance, chosen to reflect values we observed.
Var(econstruction) is entered into PoolingPlanner by speci-
fying “Array:Construction Ratio = 7:3”, as seen in Figure
7A and 7B. An exact value for var(econstruction) can also
be entered (30% of 3.3 × 10
-4 would be 9.9 × 10
-5). For
allele frequency, by default PoolingPlanner uses HapMap
CEU data (release 27) to set p to the average minor
allele frequency (MAF) on the 1M-Single, 1M-Duo, or
660-Quad Illumina array. For the 1M-Single and 1M-
Duo arrays p = 0.21 (>95% of SNPs had available Hap-
Map data), and for the 660-Quad array p = 0.29 (87% of
SNPs had available HapMap data). Estimates of p based
Figure 5 Decomposition of pooling variance for Illumina 660-Quad arrays. Stacked barplots showing the normalized pooling variance
estimates, and the breakdown into array and to pool-construction variance for pools allelotyped on the Illumina 660-Quad array. All estimates
are derived from comparison of non-identical pools, Type C. The portion of pooling variance attributed to pool-construction is indicated by
hatched bars, the portion of pooling variance attribute to the array is indicated by grey bars. Pool size is indicated above each stacked bar.
Figure 6 Decomposition of pooling variance for Illumina 1M-Duo arrays. Stacked barplots showing the normalized pooling variance
estimates, and the breakdown into array and to pool-construction variance for pools allelotyped on the Illumina 1M-Duo array. All estimates are
derived from comparison of non-identical pools, Type C. The portion of pooling variance attributed to pool-construction is indicated by hatched
bars, the portion of pooling variance attribute to the array is indicated by grey bars. Pool size is indicated above each stacked bar.
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Page 8 of 13on our pooled array data were similar (see Additional
File 4, Table S4). In this example the average MAF is
set to 0.29, but the user can enter any value between 0
and 0.5. Once these values are entered the program cal-
culates the relative and effective sample size of each
DNA pool for a range of replicate array values, and pro-
vides a corresponding table of values as seen in Figure
7A and 7B. A plot of relative sample size versus number
of replicate arrays is also automatically generated. For a
DNA pool containing 300 individuals (blue line in Fig-
ure 7C), an RSS of 80% is achieved with 6 arrays (N* is
244) while an RSS of 90% requires 13 arrays (N* is 271).
In contrast, for a pool of 1000 individuals (red line in
Figure 7C), an RSS of 80% is achieved with 19 arrays
(N* is 806). This plot makes it easy to see at what point
additional replicate arrays begin to yield diminishing
returns in terms of increasing the effective sample size
of a DNA pool.
To perform pooling-adjusted power calculations, a
pool’s effective sample size, output by PoolingPlanner, is
entered into a power calculator. We have used Quanto
[21] for this example. Assuming an unmatched case-
Figure 7 PoolingPlanner. (A) Control input and output panel for the case pool. (B) Control input and output panel for the control pool. (C)
Corresponding plot of relative sample size versus the number if replicate arrays used in allelotyping the case (blue line) and control pool (red
line).
Table 2 Impact of replicate arrays on effective sample size (N*) and minimum detectable odds ratio (MDOR) in
pooling-GWAS.
Arrays per pool Case pool
(RSS, N*)
Control pool
(RSS, N*)
MDOR at 80% (p = 0.29) MDOR at 80% (p = 0.10)
24 0.95, 284 0.84, 837 1.33 1.51
12 0.90, 269 0.72, 720 1.35 1.54
6 0.81, 244 0.56, 562 1.38 1.58
3 0.69, 206 0.39, 391 1.44 1.70
Individual Genotyping 1, 300 1, 1000 1.32 1.49
This table compares the minimum detectable odds ratios (MDOR) at 80% power for a theoretical pooling experiment with 300 cases and 1000 controls, givena
DNA-pooling strategy where 24, 12, 6, or 3 Illumina 660-Quad replicate arrays are used to allelotype each DNA pool (case and control). The equivalent individual
genotyping experiment is given for reference. Relative sample size (RSS) and effective sample size (N*) are generated by PoolingPlanner assuming var(earray)= 3.3
×1 0
-4, var(econstruction)= 9.9 × 10
-5, and an average minor allele frequency of 0.29. MDOR at 80% power were calculated using Quanto [21] assuming an
unmatched case-control design testing for gene-only effects using a log-additive model, where the incidence of the case phenotype is 0.02% and the risk allele,
p, is set to 0.29 or 0.10.
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additive model, where the incidence of the case pheno-
type is 0.02%, and the risk allele frequency (prisk)i s2 9 %
(and in complete linkage disequilibrium with a SNP on
the array), the power curves corresponding to a pooling
experiment where 3, 6, 12, or 24 Illumina 660-Quad
replicate arrays are used per pool is given in Figure 8.
The power curve for individual genotyping is also
plotted for reference. Table 2 accompanies this Figure 8
and gives the minimum detectable odds ratio (MDOR)
at 80% power for each curve when prisk is 0.29, and for
comparison, when prisk is 0.1. Assuming individual gen-
otyping, the MDOR at 80% power would be 1.32 when
prisk is 0.29. Using 24 arrays per pool this value rises
incrementally to 1.33. Using 12, 6, or 3 arrays per pool,
the MDOR’s further increase to 1.35, 1.38, and 1.44,
respectively. Only when 3 arrays are used per pool does
the MDOR dramatically differ between pooling and
individual genotyping. Marginal improvements in
MDOR should be considered in light of increasing
experimental cost, and the percent cost of a pooling
GWAS relative to a conventional GWAS is given in
Table 2 to highlight this difference. If arrays cost $250,
the ability to detect an odds ratio of 1.38 with 80%
power would cost $3,000 (6 arrays per pool), while the
ability to detect an odds ratio of 1.33 would be $325,000
(individual genotyping). In many cases, particularly for
phenotypes suggestive of moderate to large odds ratio,
this difference in detectable odds ratios will not change
of the overall outcome of the association study. In a
pooling GWAS, as in conventional GWAS, for rarer risk
alleles we have less power to detect associations, see the
MDOR in Table 2 when prisk is 0.1. We note that as
prisk gets smaller, the difference in the MDOR for a
pooling versus individual genotyping experiment
becomes more noticeable. For example, when 6 replicate
arrays are used per pool and prisk is 0.29, the MDOR
differs by 0.06 from individual genotyping, but this dif-
ference becomes 0.09 when prisk is 0.1. It is also worth
noting in Table 2 that using the same number of repli-
cate arrays on different sized DNA pools of very differ-
ent RSS values. Contrary to what might be expected, the
maximally powered pool-based experiment occurs when
arrays are equally distributed amongst pools, regardless
of differences in pool size and RSS, assuming the pool-
construction variance is constant (see Additional File 5,
Table S5 & Additional File 6, Figure S1). By conducting
an analysis such as this a user can decide what power is
forfeited by conducting a pool-based GWAS, and decide
whether the approach makes practical sense in their
situation.
Discussion
In the first part of this study we set out to establish a
range of experimentally observed values for array var-
iance on Illumina’s SNP-genotyping beadarrays. At the
same time, we wanted to establish a range of values for
pool construction variance. In the second part, we used
these estimates to calculate the effective sample size of a
DNA pool given a range of replicate array values, and
provide an online tool to allow readers to do the same.
At the time of our analysis we were aware of only one
report that estimated array variance (var(earray)= 1.1 ×
10
-4 ) for an Illumina HumanHap300 beadarray [18].
Illumina has since released higher density arrays (>1
million SNPs per array), and we wanted to determine if
increased SNP density negatively impacted array var-
iance. Overall, we found this was not the case. All of the
Illumina array types examined here (660-Quad, 1M-Sin-
gle, 1M-Duo) had very similar var(earray) estimates, cen-
tering around 3 × 10
-4 for our normalized data, which is
largely in keeping with the HumanHap300 result [18].
We expect this result would extend to the Huma-
nOmni1-Quad array, although it was not analyzed it
here. We found that the normalization procedure we
used reduced the array variance between 2-8-fold, and a
newly reported normalization algorithm suggests that
array variance can be reduced even further [24].
Figure 8 Example use of PoolingPlanner. Power curves for a
theoretical pooling experiment with 300 cases and 1000 controls
where 24, 12, 6, or 3 Illumina 660-Quad replicate arrays are used to
allelotype the DNA pools. The equivalent individual genotyping
experiment is given for reference. Effective sample size assuming 24,
12, 6, or 3 arrays was calculated using PoolingPlanner (see Table 2)
and these values entered into Quanto [21] to obtain pool-adjusted
estimates of power over a range of odds ratios. Calculations are
based on an unmatched case-control design testing for gene-only
effects using a log-additive model, where the incidence of the case
phenotype is 0.02%, and the risk allele frequency (prisk) is 29% (and
in complete linkage disequilibrium with a SNP on the array). A
dashed line is draw to indicate the 80% power threshold.
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mates of allele frequency, which should further mini-
mize the loss of power associated with using the DNA
pooling strategy.
The Illumina arrays analyzed here yielded var(earray)
estimates ~10-fold smaller than those of the Affymetrix
HindIII 50K arrays (var(earray)= 1.26 × 10
-3) analyzed by
MacGregor [17]. A similar result was noted when Affy-
metrix arrays were compared to Illumina Human-
Hap300 arrays [18]. In part, this may be explained by
differences in the manufacturing of the arrays. MacGre-
gor et al. [18] report that pooling errors appear to be
highly related to number ofp r o b e su s e dt oe s t i m a t e
SNP allele frequency. While 10 probe pairs are assigned
to each SNP on the Affymetrix HindIII 50K arrays [18],
on average 16-18 beads are used on the Illumina arrays.
Further, on Illumina arrays beads are randomly dis-
persed on a slide [22], while on Affymetrix arrays probes
are fixed in a given location, making the latter more sus-
ceptible to location-specific technical errors. As the
array variance gets smaller (i.e. when using Illumina
arrays), we expect the pool-construction variance to
account for a greater proportion of the pooling variance.
Our estimates of var(econstruction)s p a n n e d2 7D N A
pools, ranging in size from 74 to 446 individual samples,
allowing us to sample a range of possible pool construc-
tion variances. First, in contrast to a previous report
[25], we did not observe a relationship between pool
size and pool-construction variance. We did, however,
observe batch effects. For the 1M-Duo arrays, which
were processed in two batches on different dates, we
observed very different estimates of pooling variance
and pool-construction variance (see Figure 6). Most of
our estimates of pool-construction variance were based
on values from Type C comparisons, and for these var
(econstruction) usually fell between 20 and 40% of the
pooling variance. When calculations were based on the
comparison of replicate DNA pools (Type B compari-
sons, 1M-Single arrays only) our estimates were smaller,
on average 7.5% of the pooling variance. There are sev-
eral possible reasons for this. The adjustment for bino-
mial sampling variance may not fully account for the
variance arising from sampling, leaving variance that is
then attributed to pool-construction in the Type C com-
parisons. As well, some estimates of pool-construction
variance were negative, and these were set to zero,
which would lead to overestimation of pool-construction
variance. We conclude that relative to var(earray), var
(econstruction.) is of less importance; however, our results
suggest pool construction may account for more of the
pooling variance than previously estimated [17]. Mac-
Gregor [17] attributed 12.5% of the pooling variance to
pool-construction when using Affymetrix HindIII 50K
arrays. On average we attribute 30% of pooling variance
to pool construction when using Illumina arrays. This
difference is what might be expected given the smaller
var(earray) for Illumina arrays. Further reductions in
array variance, for example, through improved normali-
zation of array data, have the potential to further shift
the proportion of an experiment’s pooling variance that
is attributed to pool-construction errors.
With respect to the design of pool-based experiments
when using Illumina arrays, our partitioning of the pool-
ing variance still suggests [17] that constructing fewer
(large) pools while using more replicate arrays (i.e. target
array variance), is the most effective way to reduce pool-
ing variance and conduct the most efficient pool-based
GWAS. Further, for an equivalent pool-based experi-
ment using Affymetrix arrays in place of Illumina arrays,
more array replicates will be needed (~10-fold more). As
the proportion of array variance to pool construction
variance approaches 50:50, strategies to reduce pool
construction variance become more important.
For one of our experiments, 1M-Duo Batch 2, we
observed unusually high estimates of pool-construction
variance and low estimates of array variance (see Figure
6). In this experiment, pool replicates were allelotyped
on the same physical array (which holds two samples).
Subsequently, we noticed that the array variance for
replicates on the same chip were much smaller than the
variance for replicates on different chips. Overall, this
led to the array variance being underestimated relative
to the pooling variance, leaving more variance to be
accounted for by pool construction. In addition, the
between-chip variance for these arrays was much higher
than observed in the 1M-Duo Batch 1 dataset, which
lead to large estimates of pooling and pool-construction
variance overall. Ultimately, this was traced back to unu-
sually high red channel intensity on some arrays, despite
normalization, which biased allele frequency estimates
array-wide. Clearly this will influence any downstream
association analysis, so in this case, our analysis of var-
iance served to flag a serious problem in the array data.
It also highlighted the need to randomize DNA pool
replicates among arrays that carry more than one sam-
ple, and to randomize by location on the array, particu-
larly in the case of the 660-Quad and HumanOmni1-
Quad arrays, which carry four samples.
The differences between 1M-Duo Batch 1 and 2 data
were significant for normalized data, but not raw data.
O no n eh a n d ,i tm a yb et h a tg r e a t e rn o i s ea s s o c i a t e d
with the raw data prevented differences in array variance
and pool construction variance from being significant.
On the other, it is possible that the normalization proce-
dure itself exacerbated technical artifacts only present
on some arrays, leading to the observed differences in
normalized data. This can occur if technical artefacts
violate the assumptions of the normalization [26].
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We have provided empirical estimates of var(earray)a n d
var(econstruction) for a range of DNA pool sizes. We have
also presented PoolingPlanner, a simple program to help
translate these variances into their effect on sample size,
information that can then be use in a power calculator
to conduct pool-adjust calculations. PoolingPlanner may
be helpful in quickly assessing theoretical best and
worst-case scenarios for a DNA pooling GWAS. With
this information the user can then make a more
informed decision about how to carry out their pooling
experiment to optimally balance cost with loss of power.
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